Foundation For Sarcoidosis Research is located in Chicago, IL. The organization was established in 2012. According to its NTEE Classification (T31) the organization is classified as: Community Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 12/2021, Foundation For Sarcoidosis Research employed 11 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Foundation For Sarcoidosis Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Foundation For Sarcoidosis Research generated $2.4m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 14.7% each year . All expenses for the organization totaled $1.7m during the year ending 12/2021. While expenses have increased by 7.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Foundation For Sarcoidosis Research has awarded 67 individual grants totaling $2,876,305. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE FOUNDATION FOR SARCOIDOSIS RESEARCH (FSR) IS THE LEADING INTERNATIONAL ORGANIZATION DEDICATED TO FINDING A CURE FOR SARCOIDOSIS AND IMPROVING CARE FOR SARCOIDOSIS PATIENTS THROUGH RESEARCH, EDUCATION, AND SUPPORT. SINCE ITS ESTABLISHMENT IN 2000, FSR HAS FOSTERED OVER $6 MILLION IN SARCOIDOSIS-SPECIFIC RESEARCH EFFORTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH - FSR'S SMALL GRANT PROGRAM FOCUSES ON AWARDING FUNDS TO NEW OR EARLY STAGE RESEARCH ON SARCOIDOSIS. FSR'S CLINICAL STUDIES NETWORK(CSN) AND SARCONNECT PROGRAMS CONTINUED TO ENGAGE AND PARTNER WITH PHARMACEUTICAL COMPANIES THROUGH PATIENT OUTREACH AND RECRUITMENT FOR LARGE MULTI- CENTER TRIALS. BOTH PROGRAMS HELP CARRY OUT MULTIPLE STUDIES WITH FOCUS IN CARDIAC AND PULMONARY SARCOIDOSIS. FSR CONTINUED GROWING THE PATIENT REGISTRY AND MADE SIGNIFICANT PROGRESS ON THE SCOUTENDPOINTS PROJECT, IN ADDITION TO PROVIDING SERVICES AND SUPPORT TO ADVANCE SARCOIDOSIS RESEARCH AND THE MISSION OF THE ORGANIZATION.
THE ORGANIZATION APPROACHES THEIR MISSION OF FINDING A CURE FOR SARCOIDOSIS AND IMPROVING CARE FOR SARCOIDOSIS PATIENTS THROUGH FOLLOWING MAJOR PROGRAM AREAS: PATIENT OUTREACH AND EDUCATION PROGRAMS, PHYSICIAN OUTREACH PROGRAM AND SCIENTIFIC RESEARCH AGENDA. IN THESE PROGRAMS, VARIOUS RESOURCES AND EDUCATION ARE PROVIDING TO THE PATIENT AND THEIR LOVED ONES, NAVIGATION AND NETWORK ARE BUILT UP TO CONNECT PATIENTS, PHYSICIANS AND PEERS OF BOTH COMMUNITIES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Mary E Mcgowan CEO | Officer | 40 | $225,000 |
Craig Lipset Vice President | OfficerTrustee | 5 | $0 |
Louise M Perkins PHD President | OfficerTrustee | 10 | $0 |
Mary Cobb Secretary | OfficerTrustee | 5 | $0 |
Jim Davis Jr Treasurer | Trustee | 5 | $0 |
Emerson Hall Jr PHD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,943,444 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,943,444 |
Total Program Service Revenue | $188,396 |
Investment income | $154,644 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $98,479 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,385,283 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $367,055 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $225,000 |
Compensation of current officers, directors, key employees. | $32,176 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $543,705 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $57,182 |
Fees for services: Management | $0 |
Fees for services: Legal | $22,561 |
Fees for services: Accounting | $87,125 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $26,123 |
Fees for services: Other | $0 |
Advertising and promotion | $510 |
Office expenses | $6,954 |
Information technology | $55,155 |
Royalties | $0 |
Occupancy | $53,411 |
Travel | $1,750 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $63,133 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $10,176 |
Insurance | $5,293 |
All other expenses | $21,968 |
Total functional expenses | $1,728,967 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $803,346 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $551,531 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $23,315 |
Net Land, buildings, and equipment | $6,798 |
Investments—publicly traded securities | $4,618,383 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $668 |
Other assets | $0 |
Total assets | $6,004,041 |
Accounts payable and accrued expenses | $186,866 |
Grants payable | $112,500 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $51,166 |
Total liabilities | $350,532 |
Net assets without donor restrictions | $3,990,562 |
Net assets with donor restrictions | $1,662,947 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $6,004,041 |
Over the last fiscal year, Foundation For Sarcoidosis Research has awarded $363,505 in support to 10 organizations.
Grant Recipient | Amount |
---|---|
Baltimore, MD PURPOSE: RESEARCH | $150,000 |
UNIVERSITY OF LIVERPOOL PURPOSE: RESEARCH | $53,455 |
Evanston, IL PURPOSE: RESEARCH | $29,900 |
Independence, OH PURPOSE: RESEARCH | $28,650 |
UNIVERSITY OF MINNESOTA PURPOSE: RESEARCH | $25,000 |
Chicago, IL PURPOSE: RESEARCH | $24,000 |
Over the last fiscal year, we have identified 18 grants that Foundation For Sarcoidosis Research has recieved totaling $808,211.
Awarding Organization | Amount |
---|---|
Silicon Valley Community Foundation Mountain View, CA PURPOSE: Health | $600,000 |
Network For Good Inc Washington, DC PURPOSE: UNRESTRICTED | $61,692 |
Harlene And Marvin Wool Foundation St Louis, MO PURPOSE: IMPROVING CARE FOR SARCOIDOSIS PATIENTS AND TO FINDING A CURE FOR THIS DISEASE | $30,000 |
Schwab Charitable Fund San Francisco, CA PURPOSE: PUBLIC, SOCIETAL BENEFIT | $24,025 |
Morgan Stanley Global Impact Funding Trust Inc Indianapolis, IN PURPOSE: UNRESTRICTED GENERAL SUPPORT | $20,000 |
Biotechnology Innovation Organization Washington, DC PURPOSE: SUPPORT | $16,500 |
Organization Name | Assets | Revenue |
---|---|---|
The Community Foundatio Of Louisville Depository Inc Louisville, KY | $29,429,716 | $18,203,702 |
Quad Cities Community Foundation Bettendorf, IA | $165,771,747 | $15,098,956 |
Greater Cedar Rapids Community Foundation Cedar Rapids, IA | $223,368,352 | $26,493,454 |
Community Foundation Of St Joseph County Inc South Bend, IN | $247,009,993 | $29,572,898 |
St Louis Community Foundation St Louis, MO | $112,098,850 | $20,148,169 |
Dupage Community Foundation Downers Grove, IL | $125,703,251 | $14,295,087 |
The Community Foundation Of Louisville Corporate Depository In Louisville, KY | $17,663,337 | $10,177,129 |
Oshkosh Area Community Foundation Corporation Oshkosh, WI | $140,509,815 | $17,534,681 |
Community Foundation Of Greater Dubuque Dubuque, IA | $145,486,240 | $37,640,315 |
Community Foundation Of Greater Fort Wayne Inc Fort Wayne, IN | $181,936,459 | $11,602,152 |
Community Foundation Of Northern Illinois Rockford, IL | $141,924,845 | $12,064,778 |
Community Foundation Of Northeast Iowa Cedar Falls, IA | $163,015,524 | $24,241,546 |